Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
327 studies found for:    ICG
Show Display Options
Rank Status Study
1 Recruiting Minimally Invasive Imagery With Indocyanine Green
Condition: Neoplasms
Intervention: Drug: Indocyanine Green
2 Unknown  ICG Fluorescence Technique for the Detection of Sentinel Lymph Nodes
Condition: Malignant Neoplasm of Breast
Intervention: Procedure: ICG Fluorescence technique
3 Completed
Has Results
ICG Use in Angiography for Nasoseptal Flap Harvest
Condition: Skull Base Neoplasms
Intervention: Drug: indocyanine green
4 Recruiting ICG-based Fluorescence Imaging in Localization of Prostate Cancer and Metastatic Lymph Nodes
Condition: Prostate Cancer
Intervention: Drug: Indocyanine Green (ICG)
5 Recruiting NIR Fluorescence Imaging of Lymphatic Transport Using ICG
Condition: Rheumatoid Arthritis
Interventions: Drug: Indocyanine Green;   Device: MultiSpectral Imaging System
6 Recruiting Intravenous Indocyanine Green for Localization of Intra-thoracic Lesions
Conditions: Pulmonary Nodule, Solitary;   Pulmonary Nodule, Multiple
Intervention: Drug: ICG Intervention
7 Completed Study of the ICG Distribution in the Margins of Breast Cancer After Tumorectomy
Condition: Breast Cancer
Intervention: Drug: Indocyanine Green
8 Active, not recruiting Fluorescence Imaging + ICG Dye for Use in the Visual Diagnosis of Endometriosis
Condition: Endometriosis
Intervention: Other: Participants will receive ICG Dye
9 Unknown  Study of the ICG Distribution in Breast Tumours or in Axillary Lymph Nodes of Patients After Neoadjuvant Therapy
Condition: Breast Cancer
Intervention: Drug: Indocyanine Green
10 Active, not recruiting Detection of Lymphnodes Using ICG During RARP
Condition: Prostate Cancer
Intervention: Procedure: ICG
11 Unknown  The Use of Laser-Assisted Indocyanine Green Dye Angiography to Predict Mastectomy Skin Flap Viability
Conditions: Breast Cancer;   Breast Reconstruction;   Mastectomy
Intervention: Device: Laser-Assisted ICG Dye Angiography (SPY System)
12 Recruiting Endoscopic Perfusion Utilizing ICG Fluorescence Technology
Condition: Quality of Life
13 Recruiting Indocyanine Green for Solid Tumors
Conditions: Solid Tumor;   Neoplasms
Intervention: Drug: Indocyanine Green (ICG)
14 Recruiting Near Infrared Fluorescence Imaging With Indocyanine Green
Condition: Solitary Pulmonary Nodules
Interventions: Device: near infrared fluorescence imaging (NIFI);   Drug: Indocyanine Green
15 Completed Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer
Conditions: Colorectal Cancer;   Peritoneal Carcinomatosis
Intervention: Drug: Indocyanine Green
16 Recruiting Intraoperative Imaging of Breast Cancer With Indocyanine Green
Conditions: Invasive Ductal Carcinoma;   Invasive Lobular Carcinoma;   Ductal Carcinoma
Intervention: Drug: Indocyanine Green
17 Enrolling by invitation NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG
Conditions: Lung Cancer;   Esophageal Cancer
Intervention: Drug: Indocyanine green
18 Completed ICG Distribution Using NIF Imaging After IV Injection of ICG in Benign and Malignant Breast Cancer Tissue.
Condition: Breast Cancer.
Intervention: Drug: Indocyanine Green
19 Not yet recruiting ENB Robotic ICG Guided Surgery: A Novel Technique for Targeting Small Lung Tumors
Conditions: Non-small Cell Lung Cancer;   Thoracic Surgery
Intervention: Drug: Indocyanine Green
20 Recruiting The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery
Conditions: Colon Neoplasms;   Rectal Neoplasms;   Inflammatory Bowel Disease;   Diverticular Disease
Interventions: Procedure: Near-infrared ICG fluorescence imaging;   Procedure: Traditional bowel anastomosis;   Device: FireFly™

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.